CAD and leukemia: Supporting this, etoposide-induced chromosomal translocations driving therapy-associated leukemia have previously been shown to require caspase and CAD activity; this possibly requires minority MOMP to initiate caspase activation (Hars et al., 2006; Sim and Liu, 2001).